Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
6(40%)
Results Posted
75%(6 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_2
5
33%
Ph not_applicable
5
33%
Ph phase_1
4
27%

Phase Distribution

4

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
4(28.6%)
Phase 2Efficacy & side effects
5(35.7%)
N/ANon-phased studies
5(35.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

6

trials recruiting

Total Trials

15

all time

Status Distribution
Active(6)
Completed(8)
Terminated(1)

Detailed Status

Completed8
Recruiting5
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
6
Success Rate
88.9%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (28.6%)
Phase 25 (35.7%)
N/A5 (35.7%)

Trials by Status

active_not_recruiting17%
completed853%
terminated17%
recruiting533%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT04068649Phase 2

Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer

Recruiting
NCT06660407Phase 2

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

Recruiting
NCT02959463Phase 1

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

Active Not Recruiting
NCT03042156

Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy

Completed
NCT02699697Not Applicable

Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis

Completed
NCT06306638Phase 1

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

Recruiting
NCT05244239Phase 1

Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer

Recruiting
NCT02511522Not Applicable

Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases

Completed
NCT06556550Phase 2

Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care

Recruiting
NCT01242800Not Applicable

Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer

Completed
NCT01183481Phase 2

Aprepitant and Granisetron for the Prophylaxis of Radiation Induced Nausea and Vomiting - A Pilot Study

Terminated
NCT02575027Not Applicable

Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme

Completed
NCT02319824Phase 1

NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy

Completed
NCT01176487Not Applicable

Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34

Completed
NCT02460471Phase 2

Palliative Radiotherapy Protocol in Head and Neck Cancer

Completed

All 15 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
15